Literature DB >> 2866025

Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients.

T A Ban, W Guy, W H Wilson.   

Abstract

In the framework of a multi-national collaborative study carried out in eight countries, 768 chronic hospitalized schizophrenic patients were surveyed. Skin pigmentation was found to be present in 13 patients (1.7%), that is, within the same range (1-2.9%) of the initial reports. While the mean age and mean duration of hospitalization in the skin-pigmented population was slightly higher and larger than in the total population of our survey, no definitive relationships between sex, diagnosis, drugs and dosage of medication were revealed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866025     DOI: 10.1177/070674378503000605

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  3 in total

1.  Chlorpromazine-induced cutaneous pigmentation--effect of replacement with clozapine.

Authors:  S Lal; S Lal
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

2.  Chlorpromazine-induced skin pigmentation with short-term use in a patient with bipolar disorder: a case report.

Authors:  Santosh Loganathan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

3.  Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.

Authors:  S Lal; D Bloom; B Silver; B Desjardins; B Krishnan; J Thavundayil; T Thompson
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.